Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
NCT ID: NCT00033007
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
440 participants
INTERVENTIONAL
2001-04-30
2003-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
NCT00032981
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
NCT00032994
Motivational Therapy for Substance Users With Depression
NCT01189799
Pilot Clinical Trial of Computer-based Motivational Intervention - 1
NCT00230022
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
NCT00078143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavior Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evidence of cocaine or methamphetamine use, any reported use in past 2 weeks or positive urine screen at study intake. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment
Exclusion Criteria
* Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous problems with gambling?
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johns Hopkins Bayview Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxine Stitzer, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MATRIX/LA Addictions Research
Los Angeles, California, United States
Crossroads Managed Care Systems - Alamosa
Alamosa, Colorado, United States
Arapahoe/Douglas Mental Health Network
Littleton, Colorado, United States
Crossroads Managed Care Systems - Pueblo
Pueblo, Colorado, United States
Crossroads Managed Care Systems - Trinidad
Trinidad, Colorado, United States
LMG Programs, Inc.
Stamford, Connecticut, United States
Harbel Prevention and Recovery Center
Baltimore, Maryland, United States
Thomas Jefferson Intensive Sub. Abuse TP
Philadelphia, Pennsylvania, United States
Charleston Center
Charleston, South Carolina, United States
Circle Park Behavioral Health Services - Florence
Florence, South Carolina, United States
Circle Park Behavioral Health Services - Lake City
Florence, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTN-0006-1
Identifier Type: -
Identifier Source: org_study_id
NCT00015405
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.